Johnson & Johnson’s Brand Falters Over Its Role in the Opioid Crisis

The New York Times
The New York Times

“Johnson & Johnson is a corporation under duress on a number of fronts,” said Stephen Hahn-Griffiths, an executive at Reputation Institute, which tracks public perception of companies through regular surveys.

“It’s fair to say that the opioid trial is probably the straw that broke the camel’s back for Johnson & Johnson’s reputation,” he said. “We’ve not in recent years seen Johnson & Johnson’s reputation dip as low as it’s currently tracking.”

Get Reputation Ready

Join the conversation.

Access our Reputation Intelligence newsletter to learn more about your company’s reputation and how to win in the marketplace.